Cases 21 - 30 of 200
Sanofi-Aventis U.S. LLC et al v. Actavis LLC et al
as 1:2020cv00804
Defendant:
Hetero Labs Ltd., Belcher Pharmaceuticals, LLC, Glenmark Pharmaceuticals Ltd. and others
Plaintiff:
Sanofi Mature IP and Sanofi-Aventis U.S. LLC
Cause Of Action: 35 U.S.C. § 271
Novo Nordisk Inc. et al v. Sandoz Inc.
as 1:2020cv00747
Plaintiff:
Novo Nordisk Inc. and Novo Nordisk A/S
Defendant:
Sandoz Inc.
Cause Of Action: 35 U.S.C. § 271
Exela Pharma Sciences, LLC v. Sandoz, Inc.
as 1:2020cv00645
Plaintiff:
Exela Pharma Sciences, LLC
Defendant:
Sandoz, Inc.
Cause Of Action: 35 U.S.C. § 271
Pharmacyclics LLC et al v. Sun Pharma Global FZE et al
as 1:2020cv00403
Defendant:
Natco Pharma Ltd., Alvogen Pine Brook, LLC, Zydus Worldwide DMCC and others
Plaintiff:
Pharmacyclics LLC and Janssen Biotech, Inc.
Cause Of Action: 35 U.S.C. § 271
Otsuka Pharmaceutical Co., Ltd. et al v. Sandoz Inc. et al
as 1:2019cv02080
Plaintiff:
Otsuka Pharmaceutical Co., Ltd. and H. Lundbeck A/S
Defendant:
Sandoz International GmbH and Sandoz Inc.
Cause Of Action: 35 U.S.C. § 271
In re: Sitagliptin Phosphate ('708 & '921) Patent Litigation
as 1:2019md02902
Counter Defendant:
Merck Sharp & Dohme Corp.
Not Classified By Court:
Teva Pharmaceuticals USA, Inc., Torrent Pharma Inc., Torrent Pharmaceuticals Limited and others
Counter Claimant:
Macleods Pharmaceuticals Limited
In Re:
In re: Sitagliptin Phosphate ('708 & '921) Patent Litigation
Defendant:
Accord Healthcare, Inc., Teva Pharmaceutical Industries Ltd., Inventia Healthcare Ltd. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Merck Sharp & Dohme Corp. v. Sandoz Inc.
as 1:2019cv00312
Defendant:
Sandoz Inc.
Plaintiff:
Merck Sharp & Dohme Corp.
Cause Of Action: 35 U.S.C. § 271
Genentech, Inc. et al v. Sandoz, Inc. et al
as 1:2019cv00203
Plaintiff:
Genentech, Inc. and InterMune, Inc.
Defendant:
Sandoz AG, Sandoz International GmbH and Sandoz, Inc.
Cause Of Action: 35 U.S.C. § 271
Genentech, Inc. et al v. Sandoz, Inc. et al
as 1:2019cv00202
Plaintiff:
Genentech, Inc. and InterMune, Inc.
Defendant:
Sandoz AG, Sandoz International GmbH and Sandoz, Inc.
Cause Of Action: 35 U.S.C. § 271
Astellas US LLC et al v. Sandoz Inc.
as 1:2018cv01676
Defendant:
Sandoz Inc.
Plaintiff:
Gilead Sciences, Inc., Astellas US LLC and Astellas Pharma US, Inc.
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
